From: Viral manipulation of the cellular sumoylation machinery
 | Global Sumoylation | SUMO levels | SAE1/SAE2 | Ubc9 | E3 Ligase | SENPs | ||
---|---|---|---|---|---|---|---|---|
PIAS | RanBP2 | Mimics | ||||||
Adeno | Â | Â | CELO Gam1 [42]; ADV E1A [46] | ADV E4-ORF3: PIAS3 [64] | Â | ADV pro.? [119] | ||
Hepadna | ||||||||
Herpes | Â | Â | HSV [65] | HSV ICP0: PIAS1/3/4 [60, 65, 66] | HSV [70] | Â | Â | |
 |  |  | HCMV IE1/2 [50, 54]; HHV-6 IE1/2 [57] | HCMV IE2: PIAS1 [50] |  |  | ||
EBV LMP1? | Â | EBV/KSHV ZTA/RTA [48, 51,52,53, 55, 56]; EBV LMP1 [35] | Â | Â | KSHV bKZIP [82]; KSHV LANA [56] | EBV LMP1? | ||
Papilloma | Â | Â | Â | HPV E2 [47]; HPV E6 [58] | High risk E6: PIASy [63] | Â | Â | Â |
Parvo | Â | Â | Â | Â | B19 NS1: PIAS3 [61] | Â | Â | Â |
Polyoma | Â | Â | Â | Â | Â | Â | Â | Â |
Pox | Â | Â | Â | Â | Â | Â | Â | VACV I? [117] |
Arena | Â | Â | Â | Â | Â | Â | Â | Â |
Bunya | Â | Â | Â | Â | NP: PIAS1 [67] | Â | Â | Â |
Calici | Â | Â | Â | Â | Â | Â | Â | Â |
Corona | Â | Â | Â | Â | Â | Â | Â | Â |
Flavi | Â | Â | Â | Â | HCV: PIAS3? [62] | JEV [69] | Â | Â |
Filo | Â | Â | Â | Â | EBOV VP35: PIAS1 [68] | Â | Â | Â |
Orthomyxo | IAV RNA pol [33] | Â | Â | Â | IAV NP? [75] | Â | Â | |
Paramyxo | Â | Â | Â | Â | Â | Â | Â | |
Picorna | Â | Â | Â | Â | Â | Â | ||
Reo | Â | Â | Â | Â | Â | Â | Â | Â |
Retro | Â | Â | Â | Â | Â | Â | HIV [115] | |
Rhabdo | Â | Â | Â | Â | Â | Â | Â | Â |
Toga | Â | Â | Â | Â | Â | Â | Â | Â |